Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + capecitabine + cisplatin in advanced gastric cancer
jRCT2080220416Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Jul 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of bevacizumab in gastric cancer (GC) and esophagogastric junction cancer (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
bevacizumab
03
Conditions
gastric cancer (GC)esophagogastric junction cancer
Beyond the preview
Go deeper on jRCT2080220416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220416.